US Patent 9085626 FGFR1 agonists and methods of use
Patent 9085626 was granted and assigned to Genentech on July, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+127 characters)
Article
Patent abstract
The invention provides FGFR1 agonists, including agonistic anti-FGFR1 antibodies, and methods of using the same.
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09085626 FGFR1 agonists and methods of use US Patent 9085626 FGFR1 agonists and methods of use
Infobox
Patent Number
090856260
Patent Number
90856260
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090856260
Date of Patent
July 21, 2015
0Patent Application Number
134723520
Date Filed
May 15, 2012
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09085626 FGFR1 agonists and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09085626
Date of patent
July 21, 2015
Patent application number
13472352
Date Filed
May 15, 2012
Patent primary examiner
Find more entities like US Patent 9085626 FGFR1 agonists and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
